Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Sensory phenomena and obsessive-compulsive symptoms in Tourette syndrome following deep brain stimulation: Two case reports.

Kano Y, Matsuda N, Nonaka M, Fujio M, Kono T, Kaido T.

J Clin Neurosci. 2018 Jul 2. pii: S0967-5868(18)30571-X. doi: 10.1016/j.jocn.2018.06.046. [Epub ahead of print]

PMID:
30042071
2.

Activated FGFR3 promotes bone formation via accelerating endochondral ossification in mouse model of distraction osteogenesis.

Osawa Y, Matsushita M, Hasegawa S, Esaki R, Fujio M, Ohkawara B, Ishiguro N, Ohno K, Kitoh H.

Bone. 2017 Dec;105:42-49. doi: 10.1016/j.bone.2017.05.016. Epub 2017 Aug 10.

PMID:
28802681
3.

Evaluation of the Bitterness-Masking Effect of Powdered Roasted Soybeans.

Makita Y, Ishida T, Kobayashi N, Fujio M, Fujimoto K, Moritomo R, Fujita JI, Fujiwara SI.

Foods. 2016 Jun 18;5(2). pii: E44. doi: 10.3390/foods5020044.

4.

Proteomic analysis of bone proteins adsorbed onto the surface of titanium dioxide.

Sugimoto K, Tsuchiya S, Omori M, Matsuda R, Fujio M, Kuroda K, Okido M, Hibi H.

Biochem Biophys Rep. 2016 Jul 16;7:316-322. doi: 10.1016/j.bbrep.2016.07.007. eCollection 2016 Sep.

5.

Conditioned media from hypoxic-cultured human dental pulp cells promotes bone healing during distraction osteogenesis.

Fujio M, Xing Z, Sharabi N, Xue Y, Yamamoto A, Hibi H, Ueda M, Fristad I, Mustafa K.

J Tissue Eng Regen Med. 2017 Jul;11(7):2116-2126. doi: 10.1002/term.2109. Epub 2015 Nov 27.

6.

An Experimental Study on Guided Bone Regeneration Using a Polylactide-co-glycolide Membrane-Immobilized Conditioned Medium.

Tsuchiya S, Ohmori M, Hara K, Fujio M, Ikeno M, Hibi H, Ueda M.

Int J Oral Maxillofac Implants. 2015 Sep-Oct;30(5):1175-86. doi: 10.11607/jomi.3915.

PMID:
26394357
7.

Self-initiated coping with Tourette's syndrome: Effect of tic suppression on QOL.

Matsuda N, Kono T, Nonaka M, Fujio M, Kano Y.

Brain Dev. 2016 Feb;38(2):233-41. doi: 10.1016/j.braindev.2015.08.006. Epub 2015 Sep 8.

PMID:
26360257
8.

Sensory phenomena related to tics, obsessive-compulsive symptoms, and global functioning in Tourette syndrome.

Kano Y, Matsuda N, Nonaka M, Fujio M, Kuwabara H, Kono T.

Compr Psychiatry. 2015 Oct;62:141-6. doi: 10.1016/j.comppsych.2015.07.006. Epub 2015 Jul 17.

PMID:
26343478
9.

[Development of the Subjective Urge Scale and its usefulness in people with tic disorders].

Fujio M.

Shinrigaku Kenkyu. 2014 Oct;85(4):383-91. Japanese.

PMID:
25486845
10.
11.

Bone marrow stromal cell paracrine factors direct osteo/odontogenic differentiation of dental pulp cells.

Al-Sharabi N, Xue Y, Fujio M, Ueda M, Gjerde C, Mustafa K, Fristad I.

Tissue Eng Part A. 2014 Nov;20(21-22):3063-72. doi: 10.1089/ten.TEA.2013.0718. Epub 2014 Jun 25.

PMID:
24813721
12.

Stem cell-conditioned medium accelerates distraction osteogenesis through multiple regenerative mechanisms.

Ando Y, Matsubara K, Ishikawa J, Fujio M, Shohara R, Hibi H, Ueda M, Yamamoto A.

Bone. 2014 Apr;61:82-90. doi: 10.1016/j.bone.2013.12.029. Epub 2014 Jan 2.

PMID:
24389414
13.

Fast convergence to equilibrium for long-chain polymer melts using a MD/continuum hybrid method.

Senda Y, Fujio M, Shimamura S, Blomqvist J, Nieminen RM.

J Chem Phys. 2012 Oct 21;137(15):154115. doi: 10.1063/1.4759036.

PMID:
23083156
14.

Cytotoxicity of troglitazone through PPARĪ³-independent pathway and p38 MAPK pathway in renal cell carcinoma.

Fujita M, Yagami T, Fujio M, Tohji C, Takase K, Yamamoto Y, Sawada K, Yamamori M, Okamura N.

Cancer Lett. 2011 Dec 22;312(2):219-27. doi: 10.1016/j.canlet.2011.08.010. Epub 2011 Aug 22.

PMID:
21903322
15.

Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated skeletal tissue regeneration through the recruitment of endothelial precursors.

Fujio M, Yamamoto A, Ando Y, Shohara R, Kinoshita K, Kaneko T, Hibi H, Ueda M.

Bone. 2011 Oct;49(4):693-700. doi: 10.1016/j.bone.2011.06.024. Epub 2011 Jun 29.

PMID:
21741502
16.

Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.

Egi Y, Matsuura S, Maruyama T, Fujio M, Yuki S, Akira T.

Brain Res. 2011 May 10;1389:169-76. doi: 10.1016/j.brainres.2011.03.031. Epub 2011 Mar 21.

PMID:
21420942
17.

Biomedical applications of a real-time terahertz color scanner.

Schirmer M, Fujio M, Minami M, Miura J, Araki T, Yasui T.

Biomed Opt Express. 2010 Aug 2;1(2):354-366.

18.

Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.

Li X, Fujio M, Imamura M, Wu D, Vasan S, Wong CH, Ho DD, Tsuji M.

Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13010-5. doi: 10.1073/pnas.1006662107. Epub 2010 Jul 2.

19.

Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.

Schiefner A, Fujio M, Wu D, Wong CH, Wilson IA.

J Mol Biol. 2009 Nov 20;394(1):71-82. doi: 10.1016/j.jmb.2009.08.061. Epub 2009 Sep 2.

20.

Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production.

Liang PH, Imamura M, Li X, Wu D, Fujio M, Guy RT, Wu BC, Tsuji M, Wong CH.

J Am Chem Soc. 2008 Sep 17;130(37):12348-54. doi: 10.1021/ja8012787. Epub 2008 Aug 20.

21.

Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells.

Kinjo Y, Pei B, Bufali S, Raju R, Richardson SK, Imamura M, Fujio M, Wu D, Khurana A, Kawahara K, Wong CH, Howell AR, Seeberger PH, Kronenberg M.

Chem Biol. 2008 Jul 21;15(7):654-64. doi: 10.1016/j.chembiol.2008.05.012.

22.

Glycolipids as immunostimulating agents.

Wu D, Fujio M, Wong CH.

Bioorg Med Chem. 2008 Feb 1;16(3):1073-83. Epub 2007 Oct 13. Review.

23.

Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.

Chang YJ, Huang JR, Tsai YC, Hung JT, Wu D, Fujio M, Wong CH, Yu AL.

Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10299-304. Epub 2007 Jun 12.

24.

Aminolysis of Y-substituted phenyl X-substituted cinnamates and benzoates: effect of modification of the nonleaving group from benzoyl to cinnamoyl.

Um IH, Park YM, Fujio M, Mishima M, Tsuno Y.

J Org Chem. 2007 Jun 22;72(13):4816-21. Epub 2007 May 25.

PMID:
17523667
25.

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.

Michel ML, Keller AC, Paget C, Fujio M, Trottein F, Savage PB, Wong CH, Schneider E, Dy M, Leite-de-Moraes MC.

J Exp Med. 2007 May 14;204(5):995-1001. Epub 2007 Apr 30.

26.

1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.

Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T.

Bioorg Med Chem Lett. 2007 Feb 15;17(4):925-31. Epub 2006 Nov 22.

PMID:
17188867
27.

Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.

Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, Zajonc DM, Ben-Menachem G, Ainge GD, Painter GF, Khurana A, Hoebe K, Behar SM, Beutler B, Wilson IA, Tsuji M, Sellati TJ, Wong CH, Kronenberg M.

Nat Immunol. 2006 Sep;7(9):978-86. Epub 2006 Aug 20.

PMID:
16921381
28.
29.

Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.

Fujio M, Wu D, Garcia-Navarro R, Ho DD, Tsuji M, Wong CH.

J Am Chem Soc. 2006 Jul 19;128(28):9022-3.

PMID:
16834361
30.

(R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.

Tatsumi R, Fujio M, Takanashi S, Numata A, Katayama J, Satoh H, Shiigi Y, Maeda J, Kuriyama M, Horikawa T, Murozono T, Hashimoto K, Tanaka H.

J Med Chem. 2006 Jul 13;49(14):4374-83.

PMID:
16821797
31.

Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor alpha7 subtype imaging agent.

Ogawa M, Tatsumi R, Fujio M, Katayama J, Magata Y.

Nucl Med Biol. 2006 Apr;33(3):311-6. Epub 2006 Mar 9.

PMID:
16631079
32.

Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d.

Wu D, Zajonc DM, Fujio M, Sullivan BA, Kinjo Y, Kronenberg M, Wilson IA, Wong CH.

Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):3972-7. Epub 2006 Mar 6.

34.

Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats.

Fujio M, Nakagawa T, Sekiya Y, Ozawa T, Suzuki Y, Minami M, Satoh M, Kaneko S.

Eur J Neurosci. 2005 Dec;22(11):2744-54.

PMID:
16324108
35.

Effect of o-methyl group on rate, mechanism, and resonance contribution: aminolysis of Y-substituted phenyl X-substituted 2-methylbenzoates.

Um IH, Lee JY, Lee HW, Nagano Y, Fujio M, Tsuno Y.

J Org Chem. 2005 Jun 24;70(13):4980-7.

PMID:
15960495
36.
38.

Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice.

Nakagawa T, Fujio M, Ozawa T, Minami M, Satoh M.

Behav Brain Res. 2005 Jan 30;156(2):233-9.

PMID:
15582109
39.

Unexpectedly small ortho-oxygen substituent effects on stabilities of benzylic carbocations.

Fujio M, Keeffe JR, More O'Ferrall RA, O'Donoghue AC.

J Am Chem Soc. 2004 Aug 18;126(32):9982-92.

PMID:
15303872
40.

(+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptor.

Tatsumi R, Seio K, Fujio M, Katayama J, Horikawa T, Hashimoto K, Tanaka H.

Bioorg Med Chem Lett. 2004 Jul 16;14(14):3781-4.

PMID:
15203161
41.
43.

Synthesis and structure of the first stable phosphabismuthene.

Sasamori T, Takeda N, Fujio M, Kimura M, Nagase S, Tokitoh N.

Angew Chem Int Ed Engl. 2002 Jan 4;41(1):139-41. No abstract available.

PMID:
12491464
44.

Synthesis and evaluation of (11)C-labeled (S)-N-[[1-(2-phenylethyl) pyrrolidin-2-yl]methyl]-3-methylthiobenzamide as a PET 5-HT(1A) receptor ligand.

Fujio M, Nagata S, Kawamura K, Sugiyama N, Tanaka H, Uno K, Ishiwata K.

Nucl Med Biol. 2002 Aug;29(6):657-63.

PMID:
12234590
45.
46.

N-[1-(2-Phenylethyl)pyrrolidin-3-yl]-1-adamantanecarboxamides as novel 5-HT2 receptor antagonists.

Fujio M, Kuroita T, Sakai Y, Nakagawa H, Matsumoto Y.

Bioorg Med Chem Lett. 2000 Nov 6;10(21):2457-61.

PMID:
11078200
47.

Concurrent induction of two chiral centers from symmetrical 3, 4-disubstituted and 3,3,4-trisubstituted 4-pentenals using Rh-catalyzed asymmetric cyclizations

Tanaka M, Imai M, Fujio M, Sakamoto E, Takahashi M, Eto-Kato Y, Wu XM, Funakoshi K, Sakai K, Suemune H.

J Org Chem. 2000 Sep 8;65(18):5806-16.

PMID:
10970327
48.

N-[[1-(2-phenylethyl)pyrrolidin-2-yl]methyl]cyclohexanecarboxamides as selective 5-HT1A receptor agonists.

Fujio M, Togo Y, Tomozane H, Kuroita T, Morio Y, Katayama J, Matsumoto Y.

Bioorg Med Chem Lett. 2000 Mar 6;10(5):509-12.

PMID:
10743959
49.
50.

Supplemental Content

Support Center